KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

The Importance of Precise Scientific Communication: Nonrandomized Trials Should Not Be Described as Phase 3, and Registrational-intent Trials Should Not Be Described as Phase 2.

Brant A Inman, Andrew J Vickers

Eur Urol 87(6) 617-618

PMID40118738
PMCID-
DOI10.1016/j.eururo.2025.03.001
发表日期2025-03-21
摘要

摘要

Standardized nomenclature for clinical trials is required so that the terms phase 1 (first-in-human dose-finding trials), phase 2 (trials to determine the safety and efficacy of a drug and the value of further research), and phase 3 (randomized trials against a standard of care) reflect the actual study design in question.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。